NSAIDs
Key Concepts
Pain is often referred to as the "fifth vital sign" and should be systematically assessed during each patient encounter.
Pain is subjective; each report of pain must undergo evaluation since it significantly disrupts the quality of life.
Thousands of patients annually fail to satisfactorily manage pain due to various factors influencing pain, which are highly individualized.
Key Concepts Related to Pain
Pain Threshold: The minimum level of a stimulus that causes a person to perceive pain.
Pain Tolerance: The maximum amount of pain an individual can endure.
Acute Pain vs. Chronic Pain:
Acute pain is characterized by sudden onset and typically lasts for a shorter duration.
Chronic pain lasts longer than 3-6 months and often requires more complex management strategies.
Breakthrough Pain: Refers to short bursts of acute pain that occur against a backdrop of controlled or managed pain.
Myths or Bias: There is a common misconception that individuals are not in as much pain as they report.
Assessment: Pain assessment tools include pain rating scales that allow for the comparison of pain levels before and after treatment.
Interventions: Pain management may include both nonpharmacologic and pharmacologic strategies.
Important references include Davis Med-Surg Text, with specific tables regarding pain management: Table 11.1 (pg. 184), Table 11.2 (pg. 186), Table 11.4 (pg. 198), and Table 11.5 (pg. 200).
Pharmacological Management of Pain
Oral Analgesics: Should be the first choice for managing mild to moderate pain, administered regularly rather than on an "as needed" basis.
The intensity of pain should guide the dosing and type of analgesics used.
The aim of pain management is to enhance functional quality of life rather than achieve complete absence of pain.
Tailoring dosage to individual patient needs and critical evaluation of therapeutic responses are paramount for successful long-term pain management.
Inflammatory Process
The steps involved in the inflammatory process include:
Cellular Injury: Initiates the inflammatory response.
Vasodilation: Leads to redness and heat in the affected area.
Release of Chemical Mediators: Such as histamine, bradykinin, and leukotrienes.
Increased Vascular Permeability: Contributes to edema.
Cellular Infiltration: Resulting in pus formation.
Thrombosis: Leads to clot formation in the tissue.
Stimulation of Nerve Endings: Resulting in pain perception.
Fever Response
Fever is a result of the body's temperature regulation being reset due to pyrogen release. The various steps include:
Increased release of pyrogens.
Resetting the hypothalamic control.
Physiological responses increase body temperature (e.g., shivering, vasoconstriction).
Body reaches a new high temperature, causing warmth.
Further treatment may be required to remove pyrogens and restore normal temperature settings.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Mechanism of Action: Nonselective NSAIDs inhibit cyclooxygenase enzymes COX-1 and COX-2.
COX-1: Produces protective prostaglandins involved in gastrointestinal (GI) protection, renal function, and maintenance of homeostatic functions.
COX-2: Induced during inflammation, produces prostaglandins responsible for pain and swelling.
Therapeutic Uses of NSAIDs
NSAIDs are effective in:
Suppressing inflammation.
Providing analgesia for mild to moderate pain (e.g., osteoarthritis, rheumatoid arthritis).
Reducing fever and inhibiting platelet aggregation.
Aspirin is specifically used prophylactically to lower risks of ischemic events such as stroke and myocardial infarction.
Examples of NSAIDs
First-Generation NSAIDs (Non-Selective):
Aspirin (ASA), Ibuprofen, Naproxen, Ketorolac.
Second-Generation NSAIDs (Selective COX-2 Inhibitor):
Celecoxib.
Additional Non-Analgesic: Acetaminophen does not have anti-inflammatory properties but is used for pain and fever relief.
Aspirin (ASA) Details
Action: Inhibits the production of prostaglandins and decreases platelet aggregation.
Indications: Effective for pain, inflammation, fever, and reducing the risk of transient ischemic attacks and myocardial infarctions.
Contraindications:
Not for use in children with viral illnesses due to Reye’s syndrome risk.
Patients with increased risk of bleeding or history of peptic ulcer disease (PUD).
Side Effects: Commonly cause tinnitus, gastrointestinal distress, and may lead to GI bleeding.
Aspirin Overdose Manifestations
Mild Poisoning Symptoms: Include tinnitus, nausea, vomiting, and lethargy.
Moderate Poisoning Symptoms: Elevated doses ranging from 150-300 mg/kg leading to increased issues.
Severe Poisoning Symptoms: Greater than 300 mg/kg causing serious complications such as hyperpyrexia, respiratory alkalosis, and potential seizures.
Safe Dosage Ranges for Analgesics
Aspirin: Maximum of 4000 mg/day.
Acetaminophen: Upper limit also set at 4000 mg/day but reduced to 3000 mg/day for undernourished individuals; caution with concurrent hepatotoxic substances.
Ibuprofen: Maximum of 1200 mg/day; contraindicated in renal impairment.
Evaluation of Effectiveness
NSAIDs should lead to reduced inflammation, decreased fever, and alleviation of mild to moderate pain.
Acetaminophen is evaluated for pain relief as well as reduction in fever.
Case Studies and Practice Questions
Question regarding salicylism: Expected findings include dizziness, diarrhea, tinnitus, and headache.
Expectations for acetaminophen toxicity: Administer acetylcysteine as the antidote.
Teaching about celecoxib: Important to inform patients about potential increased risk of myocardial infarction.
Aspirin interactions: Caution with anticoagulants like warfarin due to increased bleeding risk.
Aspirin toxicity symptoms in emergency settings: Signs include abnormal vital changes and respiratory depression.
Conclusion
The understanding of nonopioid medications and their management is critical in optimizing pain relief while minimizing associated risks and adverse effects.